Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controlled and Selective Depletion of Regulatory T-cell for Cancer Treatment, Efficacy and Safety Study

NCT00986518 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT00986518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00986518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controlled and Selective Depletion of Regulatory T-cell for Cancer Treatment, Efficacy and Safety Study
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2012
Completion date
February 28, 2013
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer